Cargando…

Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Focused Review on Oral Anticoagulation

Peripheral artery disease (PAD) is a major cause of morbidity and mortality but it is usually underdiagnosed and undertreated. Patients with PAD present dysregulated procoagulant, anticoagulant, and fibrinolytic pathways leading to arterial and venous thrombosis. The risk of several ischemic-related...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rivera-Caravaca, José Miguel, Camelo-Castillo, Anny, Ramírez-Macías, Inmaculada, Gil-Pérez, Pablo, López-García, Cecilia, Esteve-Pastor, María Asunción, Orenes-Piñero, Esteban, Tello-Montoliu, Antonio, Marín, Francisco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267774/ https://www.ncbi.nlm.nih.gov/pubmed/34281167 http://dx.doi.org/10.3390/ijms22137113

Ejemplares similares

Gut Microbiota and the Quality of Oral Anticoagulation in Vitamin K Antagonists Users: A Review of Potential Implications
por: Camelo-Castillo, Anny, et al.
Publicado: (2021)

Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology
por: Vivas, David, et al.
Publicado: (2020)

Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS‐BLED and GARFIELD‐AF Bleeding Scores
por: Proietti, Marco, et al.
Publicado: (2018)

Therapeutic management and one-year outcomes in elderly patients with acute coronary syndrome
por: Orenes-Piñero, Esteban, et al.
Publicado: (2017)

Disparities in the Estimation of Glomerular Filtration Rate According to Cockcroft‐Gault, Modification of Diet in Renal Disease‐4, and Chronic Kidney Disease Epidemiology Collaboration Equations and Relation With Outcomes in Patients With Acute Coronary Syndrome
por: Rivera‐Caravaca, José Miguel, et al.
Publicado: (2018)

High medium-term incidence of major cardiovascular events in discharged patients with unstable angina
por: Herrero-Brocal, Marta, et al.
Publicado: (2023)

Conservatively managed patients with non-ST-segment elevation acute coronary syndrome are undertreated with indicated medicines
por: Candela, Elena, et al.
Publicado: (2018)

Recomendaciones sobre el tratamiento antitrombótico durante la pandemia COVID-19. Posicionamiento del Grupo de Trabajo de Trombosis Cardiovascular de la Sociedad Española de Cardiología
por: Vivas, David, et al.
Publicado: (2020)

Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2017)

Long‐Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC‐Stroke and CHA (2) DS (2)‐VASc Scores
por: Rivera‐Caravaca, José Miguel, et al.
Publicado: (2017)

Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2019)

Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers
por: Peña-Romero, Alicia Cristina, et al.
Publicado: (2022)

Evidences of SARS-CoV-2 virus air transmission indoors using several untouched surfaces: A pilot study
por: Orenes-Piñero, Esteban, et al.
Publicado: (2021)

The effect of hospital-based antithrombotic stewardship on adherence to anticoagulant guidelines
por: Dreijer, Albert R., et al.
Publicado: (2019)

Current Antithrombotic Therapy Strategies in Children with a Focus on Off-Label Direct Oral Anticoagulants—A Narrative Review
por: Moisa, Stefana Maria, et al.
Publicado: (2022)

Hydroxytyrosol: Its role in the prevention of cardiovascular diseases
por: Noguera-Navarro, Clara, et al.
Publicado: (2023)

Tendencias actuales en el tratamiento antitrombótico
por: Vivas, David, et al.
Publicado: (2022)

MiR-146a Contributes to Thromboinflammation and Recurrence in Young Patients with Acute Myocardial Infarction
por: de los Reyes-García, Ascensión M., et al.
Publicado: (2022)

Long-Term Anticoagulation in the Extreme Elderly with the Newer Antithrombotics: Safe or Sorry?
por: Chiong, Jun R, et al.
Publicado: (2013)

Antithrombotic management in patients with percutaneous coronary intervention requiring oral anticoagulation
por: Zalewski, Jarosław, et al.
Publicado: (2016)

Evolving paradigms in antithrombotic therapy for anticoagulated patients undergoing coronary stenting
por: Buccheri, Sergio, et al.
Publicado: (2019)

Antithrombotic management of patients with atrial fibrillation—Dutch anticoagulant initiatives anno 2020
por: Chu, G., et al.
Publicado: (2020)

Antithrombotic and anticoagulation therapies in cardiogenic shock: a critical review of the published literature
por: Radu, Razvan I., et al.
Publicado: (2021)

Thioterpenoids as Potential Antithrombotic Drugs: Molecular Docking, Antiaggregant, Anticoagulant and Antioxidant Activities
por: Ksenofontov, Alexander A., et al.
Publicado: (2022)

Prediction of Residual Stroke Risk in Anticoagulated Patients with Atrial Fibrillation: mCARS
por: Ding, Wern Yew, et al.
Publicado: (2021)

Salivary Immune and Metabolic Marker Analysis (SIMMA): A Diagnostic Test to Predict Caries Risk
por: Mira, Alex, et al.
Publicado: (2017)

Non-vitamin K Antagonist Oral Anticoagulants and Drug-Food Interactions: Implications for Clinical Practice and Potential Role of Probiotics and Prebiotics
por: Sánchez-Fuentes, Ana, et al.
Publicado: (2022)

Trends in antithrombotic drug use and adherence to non-vitamin K oral anticoagulants in the Netherlands
por: Hanemaaijer, Susan, et al.
Publicado: (2015)

Anticoagulant drug‐drug interactions: Highlighting the need for antithrombotic stewardship and shared decision making
por: Vazquez, Sara R., et al.
Publicado: (2022)

Confirmation of radiant catalytic ionization efficacy for airborne SARS-CoV-2 elimination indoors using “COVID19 traps”
por: Orenes-Piñero, Esteban, et al.
Publicado: (2022)

Subgingival microbiota in health compared to periodontitis and the influence of smoking
por: Camelo-Castillo, Anny J., et al.
Publicado: (2015)

New Approaches to the Role of Thrombin in Acute Coronary Syndromes: Quo Vadis Bivalirudin, a Direct Thrombin Inhibitor?
por: Esteve-Pastor, María Asunción, et al.
Publicado: (2016)

The New Oral Anticoagulants for the Treatment of Venous Thromboembolism: A New Paradigm Shift in Antithrombotic Therapy
por: Galanis, Taki, et al.
Publicado: (2014)

Optimum Antithrombotic Therapy in Patients Requiring Long-Term Anticoagulation and Undergoing Percutaneous Coronary Intervention
por: Agarwal, Nayan, et al.
Publicado: (2018)

Perioperative antithrombotic management of patients who receive direct oral anticoagulants during gastroenterological surgery
por: Fujikawa, Takahisa, et al.
Publicado: (2020)

Antithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes
por: Bonanad, Clara, et al.
Publicado: (2022)

Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation
por: Ding, Wern Yew, et al.
Publicado: (2022)

Does coagulopathy, anticoagulant or antithrombotic therapy matter in incisional hernia repair? Data from the Herniamed Registry
por: Staerkle, Ralph F., et al.
Publicado: (2018)

Optimal Antithrombotic Treatment of Patients with Atrial Fibrillation Early after an Acute Coronary Syndrome—Triple Therapy, Dual Antithrombotic Therapy with an Anticoagulant… Or, Rather, Temporary Dual Antiplatelet Therapy?
por: Limbruno, Ugo, et al.
Publicado: (2020)

Evidence for a lack of inotropic and chronotropic effects of glucagon and glucagon receptors in the human heart
por: Aranda-Domene, Ramón, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_858rm053c352qnnoubl4a7ug50